Home » Clinical Trials » Search Clinical Trials

Last updated on January 2019

An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib Docetaxel or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Brief description of study

The purpose of this study is to assess the safety and efficacy of nivolumab in combination with rucaparib, docetaxel, or enzalutamide in participants with castration-resistant prostate cancer that has spread.

Clinical Study Identifier: NCT03338790

Start Over

Southern Cancer Center Pc

Daphne, AL United States

Desert Hematology Oncology Medical Group

Rancho Mirage, CA United States

Local Institution

San Francisco, CA United States

Maryland Oncology Hematology, P.A.

Rockville, MD United States

Washington University School Of Medicine

Saint Louis, MO United States

Oncology Hematology West P.C. dba Nebraska Cancer Specialists

Omaha, NE United States

New York Oncology Hematology, P.C.

Amsterdam, NY United States

Local Institution

Caba, Argentina

Local Institution

Belo Horizonte, Brazil

Local Institution

Ijui, Brazil

Local Institution

Porto Alegre, Brazil

Local Institution

Campinas, Brazil

Local Institution

Rio de Janeiro, Brazil

Local Institution

Santa Catarina, Brazil

Local Institution

Edmonton, AB Canada

Local Institution

Vancouver, BC Canada

Local Institution

Saint John, NB Canada

Local Institution

Toronto, ON Canada

Local Institution

Monteria, Colombia

Local Institution

Medellin, Colombia

Local Institution

Besancon, France

Local Institution

Clermont-ferrand, France

Local Institution

Leon, Mexico

Local Institution

Guadalajara, Mexico

Local Institution

Culiacan, Mexico

Local Institution

Madrid, Spain

Local Institution

Pamplona, Spain

Local Institution

Bogota, Colombia

Local Institution

Villejuif, France

Northwest Georgia Oncology Centers, P.C.

Marietta, GA United States

Local Institution

Boston, MA United States

Local Institution

Lyon, France

Local Institution

Marseille, France

Local Institution

Minneapolis, MN United States

Providence Portland Medical Center

Portland, OR United States

Lehigh Valley Health Network

Allentown, PA United States

Universitaetsmedizin Goettingen

Goettingen, Germany

Uniklinik Heidelberg

Heidelberg, Germany

Westmead Hospital

Westmead, Australia

Monash Medical Centre Clayton

Clayton, Australia

Austin Hospital

Heidelberg, Australia

Local Institution

Curitiba, Brazil

Local Institution

Sao Paulo, Brazil

Universitaetsklinikum Essen

Essen, Germany

Klinikum rechts der Isar der Technischen Universitat Munchen

Munich, Germany

CHU de Quebec - Universite Laval

Quebec, QC Canada

Baptist Health Medical Group Oncology

Miami, FL United States

Universitaetsklinikum Jena

Jena, Germany

Praxisklinik Fuer Haematologie Und Onkologie

Koblenz, Germany

Jackson Oncology Associates, Pllc

Jackson, MS United States

The Moncton Hospital

Moncton, NB Canada

Juravinski Cancer Center

Hamilton, ON Canada

Centre Hospitalier De L'Universite De Montreal

Montreal, QC Canada

Norton Cancer Institute

Louisville, KY United States

Duke University

Durham, NC United States

Virginia Cancer Care Specialist, PC

Fairfax, VA United States

Instituto Medico Especializado Alexander Fleming

Capital Federal, Argentina

Hospital Britanico De Buenos Aires

Ciudad Autonoma de Buenos Aires, Argentina

Hospital Italiano De Buenos Aires

Caba, Argentina

Bradford Hill Centro de Investigaciones Clinicas

Santiago de Chile, Chile

Instituto Oncologico

Vina Del Mar, Chile

Yale University School Of Medicine

New Haven, CT United States

Tulane University

New Orleans, LA United States

Instituto Oncologico De Cordoba

Cordoba, Argentina

BC Cancer - Kelowna

Kelowna, BC Canada

Karmanos Cancer Center

Detroit, MI United States

Columbia University Medical Center (Cumc)

New York, NY United States

Chris O'Brien Lifehouse

Camperdown, Australia

ICON Cancer Center

South Brisbane, Australia

Lyell McEwin Hospital

Elizabeth Vale, Australia

Hospital Universitario Virgen Del Rocio

Sevilla, Spain

An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib Docetaxel or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Brief description of study

Volunteer Sign-up